Feasibility of MR-guided stereotactic ablative body radiotherapy of lymph node oligometastases

被引：0
|
作者：
Batumalai, V. [1 ]
Crawford, D. [1 ]
Pagulayan, C. [1 ]
Hogan, L. [1 ]
Jelen, U. [1 ]
Loo, C. [1 ]
Dunkerley, N. [1 ]
Picton, M. [1 ]
Geddes, L. [1 ]
Alvares, S. [1 ]
Sampaio, S. [1 ]
Heinke, M. [1 ]
Twentyman, T. [1 ]
Jameson, M. [1 ]
de Leon, J. [1 ]
机构：
[1] GenesisCare, Radiat Oncol, Sydney, NSW, Australia
来源：
RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO-0649
引用
收藏
页码：S584 / S584
页数：1
相关论文
共 50 条
  • [11] Stereotactic Ablative Body Radiotherapy to Treat Colorectal Oligometastases
    Saxby, H.
    Chandy, E.
    Phillips, I.
    Ezhil, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E173 - E174
  • [12] Phase I Trial of Stereotactic MR-guided Online Adaptive Radiotherapy for Ovarian Oligometastases
    Henke, L.
    Green, O.
    Curcuru, A.
    Mutic, S.
    Markovina, S.
    Schwarz, J.
    Grigsby, P.
    Robinson, C.
    Chundury, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S817 - S818
  • [13] Treatment patterns for adrenal metastases in the era of MR-guided stereotactic ablative radiotherapy
    van Vliet, C.
    Schneiders, F.
    Engelsman, A.
    Hashemi, S.
    Bahce, I.
    Haasbeek, C.
    Bruynzeel, A.
    Lagerwaard, F.
    Palacios, M.
    Becker-Commissaris, A.
    Slotman, B.
    Dickhoff, C.
    Senan, S.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S572 - S573
  • [14] Feasibility of split-course stereotactic ablative radiotherapy for oligometastases
    Paik, Eun Kyung
    Kim, Mi-Sook
    Seo, Young-Seok
    Jang, Won Il
    Kang, Jin-Kyu
    Cho, Chul-Koo
    Yoo, Hyung Jun
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (06) : 548 - 554
  • [15] Feasibility of MR-guided stereotactic body radiotherapy in 5, 2 or 1 fractions for prostate cancer
    Mohajer, J.
    Dunlop, A.
    Mitchell, A.
    Nill, S.
    Oelfke, U.
    Tree, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S290 - S290
  • [16] Feasibility of Stereotactic MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer
    Mustafayev, T. Z.
    Atalar, B.
    Gungor, G.
    Sengoz, M.
    Abacioglu, U.
    Ozyar, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E916 - E916
  • [17] MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parameters
    van Overeem Felter, Mette
    Moller, Pia Krause
    Josipovic, Mirjana
    Bekke, Susanne Norring
    Bernchou, Uffe
    Serup-Hansen, Eva
    Madsen, Kasper
    Parikh, Parag J.
    Kim, Joshua
    Geertsen, Poul
    Behrens, Claus P.
    Vogelius, Ivan R.
    Pohl, Mette
    Schytte, Tine
    Persson, Gitte Fredberg
    RADIOTHERAPY AND ONCOLOGY, 2024, 192
  • [18] MR-Guided Liver Stereotactic Body Radiotherapy (SBRT): To Adapt, or Not to Adapt?
    Kuczmarska-Haas, A.
    Yadav, P.
    Burr, A.
    Witt, J. S.
    Blitzer, G. C.
    Bassetti, M. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S146 - S147
  • [19] Feasibility of online adaptive MR-guided stereotactic Radiotherapy for Patients with Pancreatic Cancer
    von Bestenbostel, R.
    Rogowski, P.
    Nierer, L.
    Straub, K.
    Niyazi, M.
    Belka, C.
    Corradini, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S41 - S42
  • [20] Stereotactic Ablative Body Radiation Therapy (SABR) to Lymph Node Oligometastases: UK Experience and Clinical Outcome
    Goldsmith, C. S.
    Gaya, A.
    Plowman, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S182 - S182
12345